Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Indivior Pharmaceuticals (INDV) Revenue (2024 - 2025)

Indivior Pharmaceuticals (INDV) has 2 years of Revenue data on record, last reported at $357.0 million in Q4 2025.

  • For Q4 2025, Revenue rose 19.8% year-over-year to $357.0 million; the TTM value through Dec 2025 reached $1.2 billion, up 4.29%, while the annual FY2025 figure was $1.2 billion, 4.29% up from the prior year.
  • Revenue reached $357.0 million in Q4 2025 per INDV's latest filing, up from $314.0 million in the prior quarter.
  • Across five years, Revenue topped out at $357.0 million in Q4 2025 and bottomed at $266.0 million in Q1 2025.